The alpha spending function approach to interim data analyses.
暂无分享,去创建一个
D L DeMets | D. DeMets | G. Lan | G Lan | Gordon Lan
[1] T. Fleming,et al. Parameter estimation following group sequential hypothesis testing , 1990 .
[2] D. Harrington,et al. Counting Processes and Survival Analysis , 1991 .
[3] D L Demets,et al. Group sequential procedures: calendar versus information time. , 1989, Statistics in medicine.
[4] Michael A. Proschan,et al. Effects of assumption violations on type I error rate in group sequential monitoring , 1992 .
[5] S. Pocock,et al. Stopping rules and estimation problems in clinical trials. , 1988, Statistics in medicine.
[6] P. Armitage,et al. Sequential medical trials. 2nd edition. , 1975 .
[7] J. S. D. Cani,et al. Group sequential designs using a family of type I error probability spending functions. , 1990, Statistics in medicine.
[8] J. Ware,et al. Random-effects models for longitudinal data. , 1982, Biometrics.
[9] P. Canner. Monitoring treatment differences in long-term clinical trials. , 1977, Biometrics.
[10] S. Pocock,et al. Clinical Trials: A Practical Approach , 1984 .
[11] P. Meier,et al. Statistics and medical experimentation. , 1975, Biometrics.
[12] Christopher Jennison,et al. Interim analyses: the repeated confidence interval approach , 1989 .
[13] D. Siegmund. Estimation following sequential tests , 1978 .
[14] Emerson Ss,et al. Interim analyses in clinical trials. , 1990 .
[15] J. Whitehead. Overrunning and underrunning in sequential clinical trials. , 1992, Controlled Clinical Trials.
[16] A A Tsiatis,et al. Exact confidence intervals following a group sequential test. , 1984, Biometrics.
[17] D. DeMets,et al. Fundamentals of Clinical Trials , 1982 .
[18] Anastasios A. Tsiatis,et al. Exact confidence intervals following a group sequential trial: A comparison of methods , 1988 .
[19] B. Turnbull,et al. Repeated confidence intervals for group sequential clinical trials. , 1984, Controlled clinical trials.
[20] T R Fleming,et al. Symmetric group sequential test designs. , 1989, Biometrics.
[21] K Kim,et al. Point estimation following group sequential tests. , 1989, Biometrics.
[22] James H. Ware,et al. On distribution-free tests for equality of survival distributions , 1977 .
[23] Stephen L. George,et al. Fundamentals of Clinical Trials. (2nd ed.). , 1987 .
[24] N L Geller,et al. On the choice of times for data analysis in group sequential clinical trials. , 1991, Biometrics.
[25] David M. Reboussin,et al. Information and information fractions for design and sequential monitoring of clinical trials , 1994 .
[26] K Kim. Study duration for group sequential clinical trials with censored survival data adjusting for stratification. , 1992, Statistics in medicine.
[27] J M Lachin,et al. Group sequential distribution-free methods for the analysis of multivariate observations. , 1992, Biometrics.
[28] David L. DeMets,et al. Design and analysis of group sequential tests based on the type I error spending rate function , 1987 .
[29] M D Hughes,et al. Practical problems in interim analyses, with particular regard to estimation. , 1989, Controlled clinical trials.
[30] I. Bross,et al. Sequential Medical Plans. , 1952 .
[31] K Kim,et al. Study duration for clinical trials with survival response and early stopping rule. , 1990, Biometrics.
[32] D L DeMets,et al. Changing frequency of interim analysis in sequential monitoring. , 1989, Biometrics.
[33] Christopher Jennison,et al. Statistical Approaches to Interim Monitoring of Medical Trials: A Review and Commentary , 1990 .
[34] K Kim,et al. Confidence intervals following group sequential tests in clinical trials. , 1987, Biometrics.
[35] David L. DeMets,et al. Sequential Comparison of Changes with Repeated Measurements Data , 1991 .
[36] P. Armitage,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.
[37] S. Pocock. Statistical and ethical issues in monitoring clinical trials. , 1993, Statistics in medicine.
[38] David L. DeMets,et al. Stopping guidelines vs stopping rules: a practitioner's point of view , 1984 .
[39] Max Halperin,et al. More flexible sequential and non-sequential designs in long-term clinical trial , 1984 .
[40] Mitchell H. Gail,et al. Simulation Studies on Increments of the Two-Sample Logrank Score Test for Survival Time Data, with Application to Group Sequential Boundaries , 1982 .
[41] J. Whitehead,et al. A FORTRAN program for the design and analysis of sequential clinical trials. , 1983, Computers and biomedical research, an international journal.
[42] M. Weir,et al. The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .
[43] J. Haybittle,et al. Repeated assessment of results in clinical trials of cancer treatment. , 1971, The British journal of radiology.
[44] F. J. Anscombe. Sequential Medical Trials , 1963 .
[45] P. O'Brien,et al. Confidence intervals following group sequential tests. , 1986, Controlled clinical trials.
[46] D L DeMets,et al. Interim analysis: the alpha spending function approach. , 1994, Statistics in medicine.
[47] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[48] Y Pawitan,et al. Statistical interim monitoring of the Cardiac Arrhythmia Suppression Trial. , 1990, Statistics in medicine.
[49] S. Rössner,et al. Coronary Drug Project Research Group. , 1978, Atherosclerosis.
[50] Thomas Sellke,et al. Sequential analysis of the proportional hazards model , 1983 .
[51] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[52] T R Fleming,et al. Treatment evaluation in active control studies. , 1987, Cancer treatment reports.
[53] John M. Lachin,et al. Interim analyses with repeated measurements in a sequential clinical trial , 1990 .
[54] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[55] J. W. Lee,et al. Group sequential testing in clinical trials with multivariate observations: a review. , 1994, Statistics in medicine.
[56] W. Rogers,et al. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.
[57] Lippincott Williams Wilkins,et al. The early termination of clinical trials: causes, consequences, and control. With special reference to trials in the field of arrhythmias and sudden death. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. , 1994, European heart journal.
[58] K Kim,et al. Sample size determination for group sequential clinical trials with immediate response. , 1992, Statistics in medicine.
[59] Rupert G. Miller,et al. Survival Analysis , 2022, The SAGE Encyclopedia of Research Design.
[60] T. Fleming. Evaluation of active control trials in AIDS. , 1990, Journal of acquired immune deficiency syndromes.
[61] D. Zucker,et al. Sequential monitoring of clinical trials: the role of information and Brownian motion. , 1993, Statistics in medicine.
[62] E. J. Williams. Some representations of stable random variables as products , 1977 .
[63] D L DeMets,et al. Monitoring of clinical trials: issues and recommendations. , 1993, Controlled clinical trials.
[64] David L. DeMets,et al. Sequential Rank Tests with Repeated Measurements in Clinical Trials , 1992 .
[65] J M Lachin,et al. Use of spending functions for occasional or continuous monitoring of data in clinical trials. , 1993, Statistics in medicine.
[66] T. Lai. Incorporating scientific, ethical and economic considerations into the design of clinical trials in the pharmaceutical industry: a sequential approach , 1984 .
[67] P. Armitage,et al. Repeated Significance Tests on Accumulating Data , 1969 .
[68] H. Robbins. Statistical Methods Related to the Law of the Iterated Logarithm , 1970 .
[69] M H Gail,et al. Use of logrank tests and group sequential methods at fixed calendar times. , 1985, Biometrics.
[70] S. Pocock,et al. When to stop a clinical trial. , 1992, BMJ.
[71] C. Gilligan,et al. Calcium supplementation and bone loss in middle-aged women. , 1989, The American journal of clinical nutrition.
[72] J M Lachin,et al. Implementation of group sequential logrank tests in a maximum duration trial. , 1990, Biometrics.
[73] Janet Wittes,et al. Data monitoring in complex clinical trials: which treatment is better'? , 1994 .
[74] T R Fleming,et al. Approaches to monitoring clinical trials. , 1989, Journal of the National Cancer Institute.
[75] David L. DeMets,et al. Asymmetric group sequential boundaries for monitoring clinical trials , 1982 .
[76] John Whitehead,et al. On the bias of maximum likelihood estimation following a sequential test , 1986 .
[77] D L Demets,et al. Practical aspects in data monitoring: a brief review. , 1987, Statistics in medicine.
[78] David L. DeMets,et al. Statistical aspects of early termination in the beta-blocker heart attack trial , 1984 .
[79] Anastasios A. Tsiatis,et al. Repeated Significance Testing for a General Class of Statistics Used in Censored Survival Analysis , 1982 .
[80] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[81] Eric V. Slud,et al. Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic , 1982 .
[82] M C Wu,et al. Sequential monitoring for comparison of changes in a response variable in clinical studies. , 1992, Biometrics.